Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult-Onset Nonautoimmune Diabetes.

Agata JuszczakTamara PavićFrano VučkovićAmanda J BennettNeha ShahEdita Pape MedvidovićChristopher J GrovesMario ŠekerijaKyla ChandlerCarla BurrowsNataša Rojnić PutarekMarijana Vučić LovrenčićJadranka Ćuća KneževićTim J JamesAnna L GloynGordan LaucMark I McCarthyKatharine R OwenOlga Gornik

Published in: Diabetes care (2018)

Half of rare HNF1A sequence variants do not cause MODY. N-glycan profile and hs-CRP could both be used as tools, alone or as adjuncts to existing pathways, for identifying individuals at high risk of carrying a damaging HNF1A allele.

Keyphrases

nuclear factor
type diabetes
cardiovascular disease
cell surface
toll like receptor
copy number
middle aged
dna methylation
skeletal muscle
amino acid
weight loss